What is the appropriate Adderall XR (mixed amphetamine salts) dosing regimen for a 6‑year‑old child diagnosed with ADHD?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adderall XR Dosing for Age 6

For a 6-year-old child with ADHD, start Adderall XR at 5 mg once daily in the morning, then titrate upward in weekly increments of 5 mg based on symptom response and tolerability, with a maximum dose of 30 mg/day. 1

Starting Dose

The FDA-approved label for Adderall XR specifies that children aged 6-12 years should begin with 10 mg once daily when starting treatment for the first time or switching from another medication 1. However, when clinical judgment indicates a lower initial dose is appropriate, treatment may begin with 5 mg once daily in the morning 1. Given that 6 years represents the youngest approved age, starting at the lower 5 mg dose is often prudent to assess tolerability.

The 2002 AACAP practice parameter supports this approach, recommending a starting dose of 2.5 mg for mixed amphetamine salts (AMP), typically given once daily in the early morning 2. This aligns with starting at the lower end of the dosing range for young children.

Titration Schedule

Increase the dose in weekly increments of 5 mg if ADHD symptoms are not adequately controlled 1. The systematic titration approach involves:

  • Week 1: 5 mg once daily (if starting low) or 10 mg once daily
  • Week 2: 10 mg once daily
  • Week 3: 15 mg once daily
  • Week 4: 20 mg once daily

Continue titrating until symptoms are controlled or side effects emerge 2.

Maximum Dose

The maximum recommended dose for children aged 6-12 is 30 mg/day 1. The FDA label explicitly states that "doses greater than 30 mg/day of ADDERALL XR have not been studied in children" 1. The 2002 AACAP guidelines note that expert consensus often limits the upper range to a total daily dose of 40 mg for amphetamines, though this exceeds FDA recommendations 2.

For children weighing less than 25 kg (approximately 55 lbs), single doses should generally not exceed 10 mg of mixed amphetamine salts 2. Given that many 6-year-olds weigh less than this threshold, particular caution is warranted with dose escalation.

Administration Details

  • Give once daily upon awakening 1
  • Avoid afternoon doses due to potential for insomnia 1
  • May be taken with or without food 1
  • Capsules may be swallowed whole or opened and sprinkled on applesauce (consume immediately without chewing) 1

Monitoring Requirements

Before initiating treatment, obtain:

  • Baseline blood pressure, pulse, height, and weight 2
  • Cardiac history including family history of sudden death, structural cardiac abnormalities, arrhythmias 1

During titration:

  • Weekly contact (office visit or phone) to assess symptom response and side effects 2
  • Obtain parent and teacher rating scales (e.g., ADHD-RS-IV) to guide dose adjustments 2
  • Monitor for common side effects: decreased appetite, insomnia, irritability, headache 3, 4

Important Caveats

Age 6 represents the lower boundary of FDA approval for Adderall XR 1. The 2011 AAP guidelines emphasize that for preschool-aged children (4-5 years), behavioral therapy should be first-line treatment, with medication reserved for moderate-to-severe cases that fail behavioral interventions 5. While a 6-year-old falls within the approved age range, ensure ADHD diagnosis is robust and consider whether behavioral interventions have been adequately tried.

Titrate slowly in young children to minimize unnecessary side effects, which can decrease willingness to continue treatment 2. The 2002 AACAP parameter specifically warns to "take care to titrate slowly with small children and to stop or to reverse the dose increase when side effects occur" 2.

Growth monitoring is essential: Recent meta-analyses show stimulants cause modest growth attenuation (1-2 cm), particularly at higher doses 5. Monitor height and weight at each visit 2.

The evidence supports flexible dose titration based on individual response rather than weight-based dosing, as weight-adjusted dosing has not been consistently validated and creates practical problems with pill splitting 2. A 2022 meta-analysis confirmed that flexible-dose titration strategies demonstrate superior efficacy and acceptability compared to fixed-dose approaches 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.